Literature DB >> 1247369

Nerve conduction velocity determinations in juvenile diabetes: continuing study of 190 patients.

G D Eng, W Hung, G P August, M D Smokvina.   

Abstract

Few prospective studies on the concomitant finding of neuropathy in juvenile diabetics exist. An ongoing study of motor and sensory nerve conduction determinations in 190 diabetic children, with sequential studies in 108 of them over an eight-year period, is the subject of this report. The incidence of neuropathy in our sample population under five years of age is neglible. In the children over five years of age, 8% had abnormal nerve conduction velocity (NCV) of the peroneal nerve, 4.5% had abnormal median motor and sensory NCV on initial study. In the sequential studies of the children over five years of age, the percentage of abnormal NCV rose from 14% to 48% as the duration of diabetes increased from one year to more than five years. It is the older juvenile diabetics with the longest duration of diabetes who would appear to have the highest incidence of neuropathy.

Entities:  

Mesh:

Year:  1976        PMID: 1247369

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Nerve conduction in children suffering insulin dependent diabetes mellitus.

Authors:  Funda Cenesiz; Birkan Sonel Tur; Tahsin Tezic; Yavuz Gurer
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

2.  Peripheral nerve abnormalities in newly-diagnosed diabetic children.

Authors:  G Comi; N Canal; L Lozza; L Beccaria; F Meschi; R Vanini; A F D'Arcais; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  Posturally induced vasoconstriction in diabetes mellitus.

Authors:  A C Shore; K J Price; D D Sandeman; J H Tripp; J E Tooke
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

4.  Ocular Complications in Children with Diabetes Mellitus.

Authors:  Megan M Geloneck; Brian J Forbes; James Shaffer; Gui-shuang Ying; Gil Binenbaum
Journal:  Ophthalmology       Date:  2015-09-01       Impact factor: 12.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.